a2z Radiology AI receives FDA clearance for abdomen-pelvis CT device
a2z Radiology AI has secured approval from the US Food and Drug Administration (FDA) for its a2z-Unified-Triage, a multi-condition triage…
All articles by Vidyasagar Maddela
Vidyasagar Maddela
-
-
Örebro University researchers develop new AI models for dementia
Scientists at Örebro University in Sweden have developed two new AI models that can differentiate between healthy individuals and patients…
-
Biogen acquires Alcyone to boost CNS drug delivery
Biogen has completed its previously announced acquisition of US-based Alcyone Therapeutics, for an upfront cash payment of $85m, to boost…
-
Zimmer Biomet secures FDA approval for ROSA Knee with OptimiZe system
Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology.…
-
Adagio Medical secures $19m to support ULTC system
Adagio Medical has secured $19m upfront through a private placement, aimed at advancing its ultra-low temperature cryoablation (ULTC) technology for…
-
BD launches AI-powered Incada Platform for healthcare connectivity
Becton, Dickinson and Company (BD) has launched the Incada Connected Care Platform, an AI-powered cloud-based system designed to integrate data…
-
VIVATRONIX and SpineX announce xStep device approval from CDSCO
VIVATRONIX Tech and SpineX have announced approval from India’s Central Drugs Standard Control Organisation (CDSCO) for the xStep device to…
-
Monteris and Symphony partner on laser ablation platform
Monteris Medical and Symphony Robotics have entered a strategic collaboration aimed at enhancing precision in laser ablation procedures for complex…
-
AtaCor raises $75m for trial of EV-ICD system
AtaCor Medical has announced up to $75m in financing to support a pivotal study of its extravascular implantable cardioverter-defibrillator (EV-ICD)…
-
Roche and KlinRisk’s AI-powered kidney tool gains CE mark
Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the progression of…